Second Sight Medical Prod...

NASDAQ: EYES · Real-Time Price · USD
4.14
-0.22 (-5.05%)
At close: Aug 31, 2022, 4:00 AM

Second Sight Medical Products Revenue Breakdown

Period Ending Dec 31, 2018
Argus I I Product Revenue 6.9M
Argus I I Product Revenue Growth n/a

Operating Expense Breakdown

Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 2.13M 1.47M 975K 1.53M 1.34M 2.47M 1.34M 1.06M 1.52M 2.72M 3.34M 3.49M 3.94M 4.55M 4.89M 5.37M 5.51M 6.25M 5.27M 4.9M 5.35M 4.98M 4.96M 4.87M 4.82M 4.42M 4.65M 4.56M 4.3M 3.65M
Selling, General, and Administrative Revenue Growth +44.95% +50.36% -36.27% +14.35% -45.87% +83.93% +26.55% -29.95% -44.31% -18.60% -4.07% -11.63% -13.33% -6.89% -8.99% -2.52% -11.89% +18.60% +7.57% -8.32% +7.48% +0.30% +1.93% +1.00% +8.98% -4.99% +2.17% +5.98% +17.73% n/a
Research and Development Revenue 843K 645K 644K 697K 695K 334K 347K 279K 323K 3.89M 4.14M 3.38M 3.44M 2.18M 2.44M 2.67M 2.42M 2.47M 2.27M 1.83M 1.95M 1.85M 2.08M 1.59M 916K 762K 546.56K 592.82K 848.76K 1.05M
Research and Development Revenue Growth +30.70% +0.16% -7.60% +0.29% +108.08% -3.75% +24.37% -13.62% -91.69% -6.22% +22.67% -1.66% +57.40% -10.46% -8.76% +10.32% -2.10% +8.94% +24.37% -6.31% +5.52% -11.24% +31.05% +73.36% +20.21% +39.42% -7.80% -30.15% -19.00% n/a